Member Info for Pugg1ey

you clearly missed the other RNS about the FDA wanting more info around CCP-07 Vernalis plc announces today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for CCP-07. A CRL is issued by the FDA when it has completed its review of an NDA and questions remain that preclude its approval at this time. The CRL did not raise any concerns with the formulation or pharmacokinetic profile of CCP-07 but did identify outstanding items that need to be addressed prior to the resubmission and approval of the NDA. "We remain committed to the approval of CCP-07 and will work closely with the FDA to resubmit the NDA as quickly as possible" said Ian Garland, CEO of Vernalis plc. Vernalis plc announces today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Application (NDA) for CCP-07. A CRL is issued by the FDA when it has completed its review of an NDA and questions remain that preclude its approval at this time. The CRL did not raise any concerns with the formulation or pharmacokinetic profile of CCP-07 but did identify outstanding items that need to be addressed prior to the resubmission and approval of the NDA. "We remain committed to the approval of CCP-07 and will work closely with the FDA to resubmit the NDA as quickly as possible" said Ian Garland, CEO of Vernalis plc.

Regarding London 'Sales rates are softer than last year' 'We are taking price action on a number of our sites in London'

I'd stay in hibernation if I were you

and then some git comes along and p***es on your birthday cake

well predicted

try reading the whole RNS

didn't last long!

don't hold but MMs all going red. I'm sure they'll have their fun while the RNS is pending